RSV recombinant candidate vaccine G1F/M2 with CpG as an adjuvant prevents vaccine-associated lung inflammation, which may be associated with the appropriate types of immune memory in spleens and lungs

• Asıl Yazarlar: Na Li (Yazar), Ling Zhang (Yazar), Boyang Zheng (Yazar), Wenjian Li (Yazar), Jianxun Liu (Yazar), Huixian Zhang (Yazar), Ruihong Zeng (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Taylor & Francis Group, 2019-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Respiratory syncytial virus (RSV) is a major respiratory pathogen in infants. The early formalin-inactivated RSV not only failed to protect infants against infection, but also was associated with enhanced pulmonary inflammatory disease upon natural infection. A safe and effective vaccine should prev...